Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Adv Clin Chem ; 99: 1-48, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32951635

RESUMEN

Every cell in the body secretes extracellular vesicles (EVs) possibly as cellular signaling components and these cell-derivatives can be found in multiple numbers in biological fluids. EVs have in the scientific field received great attention in relation to pathophysiology and disease diagnostics. Altered protein expressions associated with circulating EVs in diseased individuals can serve as biomarkers for different disease states. This capacity paves the way for non-invasive screening tools and early diagnostic markers. However, no isolation method of EVs has been acknowledged as the "golden standard," thus reproducibility of the studies remains inadequate. Increasing interest in EV proteins as disease biomarkers could give rise to more scientific knowledge with diagnostic applicability. In this chapter, studies of proteins believed to be associated with EVs within cancer, autoimmunity, metabolic and neurodegenerative diseases have been outlined.


Asunto(s)
Vesículas Extracelulares/química , Proteínas/análisis , Animales , Enfermedades Autoinmunes/diagnóstico , Biomarcadores/análisis , Humanos , Enfermedades Metabólicas/diagnóstico , Neoplasias/diagnóstico , Enfermedades Neurodegenerativas/diagnóstico
2.
Ugeskr Laeger ; 181(24)2019 Jun 10.
Artículo en Danés | MEDLINE | ID: mdl-31267953

RESUMEN

In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.


Asunto(s)
Síndrome de Fatiga Crónica , Biomarcadores , Síndrome de Fatiga Crónica/diagnóstico , Síndrome de Fatiga Crónica/genética , Síndrome de Fatiga Crónica/inmunología , Humanos , Mitocondrias , Dolor
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA